These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 24875882)
21. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211 [TBL] [Abstract][Full Text] [Related]
22. Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP. Frigon L; Pascal JM Nucleic Acids Res; 2023 Dec; 51(22):12492-12507. PubMed ID: 37971310 [TBL] [Abstract][Full Text] [Related]
23. Players in ADP-ribosylation: Readers and Erasers. Verheugd P; Bütepage M; Eckei L; Lüscher B Curr Protein Pept Sci; 2016; 17(7):654-667. PubMed ID: 27090904 [TBL] [Abstract][Full Text] [Related]
24. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro. Lin KY; Huang D; Kraus WL Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863 [TBL] [Abstract][Full Text] [Related]
26. Nucleolar-nucleoplasmic shuttling of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation and by nucleolar transcription. Bütepage M; Preisinger C; von Kriegsheim A; Scheufen A; Lausberg E; Li J; Kappes F; Feederle R; Ernst S; Eckei L; Krieg S; Müller-Newen G; Rossetti G; Feijs KLH; Verheugd P; Lüscher B Sci Rep; 2018 Apr; 8(1):6748. PubMed ID: 29712969 [TBL] [Abstract][Full Text] [Related]
27. The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions. Fehr AR; Singh SA; Kerr CM; Mukai S; Higashi H; Aikawa M Genes Dev; 2020 Mar; 34(5-6):341-359. PubMed ID: 32029454 [TBL] [Abstract][Full Text] [Related]
28. Hydrolysis of ADP-Ribosylation by Macrodomains. Posavec Marjanovic M; Jankevicius G; Ahel I Methods Mol Biol; 2018; 1813():215-223. PubMed ID: 30097870 [TBL] [Abstract][Full Text] [Related]
29. Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome. Zhang Y; Wang J; Ding M; Yu Y Nat Methods; 2013 Oct; 10(10):981-4. PubMed ID: 23955771 [TBL] [Abstract][Full Text] [Related]
30. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes. Wigle TJ; Church WD; Majer CR; Swinger KK; Aybar D; Schenkel LB; Vasbinder MM; Brendes A; Beck C; Prahm M; Wegener D; Chang P; Kuntz KW SLAS Discov; 2020 Mar; 25(3):241-252. PubMed ID: 31855104 [TBL] [Abstract][Full Text] [Related]
33. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. Kerns JA; Emerman M; Malik HS PLoS Genet; 2008 Jan; 4(1):e21. PubMed ID: 18225958 [TBL] [Abstract][Full Text] [Related]
34. Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity. Brady PN; Goel A; Johnson MA Microbiol Mol Biol Rev; 2019 Mar; 83(1):. PubMed ID: 30567936 [TBL] [Abstract][Full Text] [Related]
35. A role of intracellular mono-ADP-ribosylation in cancer biology. Scarpa ES; Fabrizio G; Di Girolamo M FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234 [TBL] [Abstract][Full Text] [Related]
36. The Promise of Proteomics for the Study of ADP-Ribosylation. Daniels CM; Ong SE; Leung AK Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340 [TBL] [Abstract][Full Text] [Related]